Deubiquitinase inhibition as a cancer therapeutic strategy.

[1]  D. Marsh,et al.  Histone H2B monoubiquitination: roles to play in human malignancy. , 2015, Endocrine-related cancer.

[2]  B. Dumitriu,et al.  Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia. , 2015, Blood.

[3]  S. Linder,et al.  Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress. , 2014, Antioxidants & redox signaling.

[4]  D. Misceo,et al.  Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms. , 2014, European journal of medical genetics.

[5]  B. Spencer‐Dene,et al.  The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. , 2014, The Journal of clinical investigation.

[6]  Xianghuo He,et al.  miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25 , 2014, Molecular Cancer.

[7]  L. Ward,et al.  A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours , 2014, British Journal of Cancer.

[8]  Elias S. J. Arnér,et al.  The 19S Deubiquitinase Inhibitor b-AP15 Is Enriched in Cells and Elicits Rapid Commitment to Cell Death , 2014, Molecular Pharmacology.

[9]  A. Kwiecińska,et al.  Amplification of 2p as a Genomic Marker for Transformation in Lymphoma , 2014, Genes, chromosomes & cancer.

[10]  Paul Pavlidis,et al.  Network Analyses Reveal Pervasive Functional Regulation Between Proteases in the Human Protease Web , 2014, PLoS biology.

[11]  A. Leask,et al.  miR-218 regulates focal adhesion kinase–dependent TGFβ signaling in fibroblasts , 2014, Molecular biology of the cell.

[12]  R. Freire,et al.  USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination , 2014, Oncogene.

[13]  Dennis L. Buckley,et al.  Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system. , 2014, Angewandte Chemie.

[14]  Daniel C. Liebler,et al.  Alkylation Damage by Lipid Electrophiles Targets Functional Protein Systems* , 2014, Molecular & Cellular Proteomics.

[15]  Yuhuang Li,et al.  Monoubiquitination Is Critical for Ovarian Tumor Domain-containing Ubiquitin Aldehyde Binding Protein 1 (Otub1) to Suppress UbcH5 Enzyme and Stabilize p53 Protein* , 2014, Journal of Biological Chemistry.

[16]  J. Coulson,et al.  The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells , 2013, Oncogene.

[17]  Yinyin Li,et al.  USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors , 2013, Cell Research.

[18]  P. Richardson,et al.  A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. , 2014, Blood.

[19]  Ziad M. Eletr,et al.  Regulation of proteolysis by human deubiquitinating enzymes. , 2014, Biochimica et biophysica acta.

[20]  Yan Cao,et al.  USP28 is a potential prognostic marker for bladder cancer , 2014, Tumor Biology.

[21]  Zhaojian Liu,et al.  USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation. , 2013, Cell reports.

[22]  Ling Zhang,et al.  A Human XPC Protein Interactome—A Resource , 2013, International journal of molecular sciences.

[23]  P. Kuzmič,et al.  Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance , 2013, Proceedings of the National Academy of Sciences.

[24]  H. Ohdan,et al.  The USP21 Short Variant (USP21SV) Lacking NES, Located Mostly in the Nucleus In Vivo, Activates Transcription by Deubiquitylating ubH2A In Vitro , 2013, PloS one.

[25]  S. Xiao,et al.  Ubiquitin-Specific Proteases 25 Negatively Regulates Virus-Induced Type I Interferon Signaling , 2013, PloS one.

[26]  Chi Wang,et al.  The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells. , 2013, Cell reports.

[27]  Jianping Cao,et al.  OTUD5 Regulates p53 Stability by Deubiquitinating p53 , 2013, PloS one.

[28]  J. Tavernier,et al.  The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response , 2013, Nature Cell Biology.

[29]  W. O,et al.  The ubiquitin specific protease USP34 promotes ubiquitin signaling at DNA double-strand breaks , 2013, Nucleic acids research.

[30]  A. Bode,et al.  USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer , 2013, Clinical Cancer Research.

[31]  Jun Du,et al.  Deubiquitinase Inhibition of 19S Regulatory Particles by 4-Arylidene Curcumin Analog AC17 Causes NF-κB Inhibition and p53 Reactivation in Human Lung Cancer Cells , 2013, Molecular Cancer Therapeutics.

[32]  M. Pagano,et al.  USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110 , 2013, Nature.

[33]  T. Kislinger,et al.  The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover , 2013, Cell Death and Differentiation.

[34]  Nathanael S Gray,et al.  Developing irreversible inhibitors of the protein kinase cysteinome. , 2013, Chemistry & biology.

[35]  C. Perez-stable,et al.  Betulinic Acid Selectively Increases Protein Degradation and Enhances Prostate Cancer-Specific Apoptosis: Possible Role for Inhibition of Deubiquitinase Activity , 2013, PloS one.

[36]  D. Lane,et al.  The deubiquitinating enzyme USP 2 a regulates the p 53 pathway by targeting Mdm 2 , 2013 .

[37]  S. Linder,et al.  Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system , 2013, Investigational New Drugs.

[38]  Ying Zhang,et al.  USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. , 2012, The Journal of clinical investigation.

[39]  A. Ma,et al.  A20: linking a complex regulator of ubiquitylation to immunity and human disease , 2012, Nature Reviews Immunology.

[40]  P. Cao,et al.  Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47. , 2012, ACS medicinal chemistry letters.

[41]  Parantu K. Shah,et al.  A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. , 2012, Cancer cell.

[42]  S. Schreiber,et al.  Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs , 2012, Proceedings of the National Academy of Sciences.

[43]  S. Grimm,et al.  De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1. , 2012, Biochimica et biophysica acta.

[44]  A. Israël,et al.  The Ubiquitin-specific Protease 12 (USP12) Is a Negative Regulator of Notch Signaling Acting on Notch Receptor Trafficking toward Degradation* , 2012, The Journal of Biological Chemistry.

[45]  Guanghui Wang,et al.  Ataxin-3 Regulates Aggresome Formation of Copper-Zinc Superoxide Dismutase (SOD1) by Editing K63-linked Polyubiquitin Chains* , 2012, The Journal of Biological Chemistry.

[46]  E. Domany,et al.  RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. , 2012, Molecular cell.

[47]  G. Sapkota,et al.  USP11 augments TGFβ signalling by deubiquitylating ALK5 , 2012, Open Biology.

[48]  N. Grishin,et al.  BAP1 loss defines a new class of renal cell carcinoma , 2012, Nature Genetics.

[49]  Jianxun Song,et al.  USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. , 2012, Molecular cell.

[50]  Jie J. Zheng,et al.  Identification Of Small Molecule TRABID Deubiquitinase Inhibitors By Computation-Based Virtual Screen , 2012, BMC chemical biology.

[51]  V. Quesada,et al.  Deubiquitinases in cancer: new functions and therapeutic options , 2012, Oncogene.

[52]  G. Marfany,et al.  Ubiquitin-Specific Protease 25 Functions in Endoplasmic Reticulum-Associated Degradation , 2012, PloS one.

[53]  A. Amerik,et al.  Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes , 2012, Cell cycle.

[54]  G. Kristiansen,et al.  The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma , 2012, Nature.

[55]  V. Battaglia,et al.  Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. , 2012, Chemistry & biology.

[56]  P. Coffino,et al.  Functional Asymmetries of Proteasome Translocase Pore* , 2012, The Journal of Biological Chemistry.

[57]  I. D'Agnano,et al.  Shotgun proteomics and network analysis of neuroblastoma cell lines treated with curcumin. , 2012, Molecular bioSystems.

[58]  Jack Taunton,et al.  Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles , 2012, Nature chemical biology.

[59]  M. Loda,et al.  The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer , 2012, Cell cycle.

[60]  Han Liu,et al.  Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions , 2012, Molecular biology of the cell.

[61]  V. Dixit,et al.  Regulation of NF‐κB by deubiquitinases , 2012, Immunological reviews.

[62]  J. Baselga,et al.  USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma , 2012, Nature Medicine.

[63]  Noula Shembade,et al.  Regulation of NF-κB signaling by the A20 deubiquitinase , 2012, Cellular and Molecular Immunology.

[64]  A. DeCaprio,et al.  Application of the Hard and Soft, Acids and Bases (HSAB) theory to toxicant--target interactions. , 2012, Chemical research in toxicology.

[65]  A. Brik,et al.  Targeting deubiquitinases enabled by chemical synthesis of proteins. , 2012, Journal of the American Chemical Society.

[66]  T. Kietzmann,et al.  GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α. , 2012, Blood.

[67]  V. Dixit,et al.  Phosphorylation-dependent activity of the deubiquitinase DUBA , 2012, Nature Structural &Molecular Biology.

[68]  M. Dai,et al.  Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1 , 2012, The EMBO journal.

[69]  Gabriel C. Lander,et al.  Complete subunit architecture of the proteasome regulatory particle , 2011, Nature.

[70]  G. Kristiansen,et al.  The deubiquitinase USP 9 X suppresses pancreatic ductal adenocarcinoma , 2012 .

[71]  Y. Saeki,et al.  Assembly and function of the proteasome. , 2012, Methods in molecular biology.

[72]  K. Vousden,et al.  Regulation of p53 stability and function by the deubiquitinating enzyme USP42 , 2011, The EMBO journal.

[73]  Mårten Fryknäs,et al.  Inhibition of proteasome deubiquitinating activity as a new cancer therapy , 2011, Nature Medicine.

[74]  K. Lindsten,et al.  Ubiquitin-specific Protease 19 (USP19) Regulates Hypoxia-inducible Factor 1α (HIF-1α) during Hypoxia* , 2011, The Journal of Biological Chemistry.

[75]  A. Jadhav,et al.  Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. , 2011, Chemistry & biology.

[76]  G. Dianov,et al.  Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. , 2011, Chemistry & biology.

[77]  A. García-Sastre,et al.  Arterivirus and Nairovirus Ovarian Tumor Domain-Containing Deubiquitinases Target Activated RIG-I To Control Innate Immune Signaling , 2011, Journal of Virology.

[78]  J. Coulson,et al.  Isoform‐Specific Localization of the Deubiquitinase USP33 to the Golgi Apparatus , 2011, Traffic.

[79]  Leonardo Morsut,et al.  USP15 is a deubiquitylating enzyme for receptor-activated SMADs , 2011, Nature Cell Biology.

[80]  B. Kessler,et al.  Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases , 2011, Expert Reviews in Molecular Medicine.

[81]  Eric F. Johnson,et al.  Ubiquitin-specific Cysteine Protease 2a (USP2a) Regulates the Stability of Aurora-A , 2011, The Journal of Biological Chemistry.

[82]  H. Ke,et al.  Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13 , 2011, Cell.

[83]  R. Roden,et al.  Stressing the Ubiquitin-Proteasome System without 20S Proteolytic Inhibition Selectively Kills Cervical Cancer Cells , 2011, PloS one.

[84]  Xiaolu Yang,et al.  The USP19 Deubiquitinase Regulates the Stability of c-IAP1 and c-IAP2* , 2011, The Journal of Biological Chemistry.

[85]  J. V. van Deursen,et al.  Overexpression of Ubiquitin Specific Protease 44 (USP44) Induces Chromosomal Instability and Is Frequently Observed in Human T-Cell Leukemia , 2011, PloS one.

[86]  S. High,et al.  Eeyarestatin 1 Interferes with Both Retrograde and Anterograde Intracellular Trafficking Pathways , 2011, PloS one.

[87]  T. Golub,et al.  Selective killing of cancer cells with a small molecule targeting stress response to ROS , 2011, Nature.

[88]  C. Sander,et al.  The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma , 2011, Nature Genetics.

[89]  Carlos Bustamante,et al.  ClpX(P) Generates Mechanical Force to Unfold and Translocate Its Protein Substrates , 2011, Cell.

[90]  A. D’Andrea,et al.  The USP1/UAF1 Complex Promotes Double-Strand Break Repair through Homologous Recombination , 2011, Molecular and Cellular Biology.

[91]  M. Mattern,et al.  Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format. , 2011, Assay and drug development technologies.

[92]  Adrian Whitty,et al.  The resurgence of covalent drugs , 2011, Nature Reviews Drug Discovery.

[93]  C. Lacroix,et al.  The Ubiquitin-Specific Protease USP34 Regulates Axin Stability and Wnt/β-Catenin Signaling , 2011, Molecular and Cellular Biology.

[94]  G. Dianov,et al.  USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase β. , 2011, Molecular cell.

[95]  D. Malide,et al.  JTV1 co‐activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress , 2011, The EMBO journal.

[96]  J. F. Burrows,et al.  The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility , 2011, Nature communications.

[97]  G. Dianov,et al.  Regulation of DNA repair by ubiquitylation , 2011, Biochemistry (Moscow).

[98]  S. Xiao,et al.  The Leader Proteinase of Foot-and-Mouth Disease Virus Negatively Regulates the Type I Interferon Pathway by Acting as a Viral Deubiquitinase , 2011, Journal of Virology.

[99]  Muzamil Ahmad,et al.  Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury , 2011, Neurobiology of Disease.

[100]  W. Au,et al.  A20, ABIN-1/2, and CARD11 Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma , 2011, Clinical Cancer Research.

[101]  S. Wing,et al.  Identification of Distinctive Patterns of USP19-Mediated Growth Regulation in Normal and Malignant Cells , 2011, PloS one.

[102]  P. Cheung,et al.  USP10 deubiquitylates the histone variant H2A.Z and both are required for androgen receptor-mediated gene activation , 2011, Nucleic acids research.

[103]  M. Dai,et al.  Positive regulation of p 53 stability and activity by the deubiquitinating enzyme , 2011 .

[104]  Hengbin Wang,et al.  Regulation of Histone H2A and H2B Deubiquitination and Xenopus Development by USP12 and USP46* , 2010, The Journal of Biological Chemistry.

[105]  E. Dmitrovsky,et al.  Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia. , 2010, Cancer research.

[106]  N. Donato,et al.  Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. , 2010, Cancer research.

[107]  J. Fellenberg,et al.  Silencing of the UCHL1 gene in giant cell tumors of bone , 2010, International journal of cancer.

[108]  M. Cazales,et al.  A screen for deubiquitinating enzymes involved in the G2/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability , 2010, Cell cycle.

[109]  David Baker,et al.  Quantitative reactivity profiling predicts functional cysteines in proteomes , 2010, Nature.

[110]  Min Jae Lee,et al.  Trimming of Ubiquitin Chains by Proteasome-associated Deubiquitinating Enzymes* , 2010, Molecular & Cellular Proteomics.

[111]  R. Hartmann-Petersen,et al.  Regulation of NF-κB activity and inducible nitric oxide synthase by regulatory particle non-ATPase subunit 13 (Rpn13) , 2010, Proceedings of the National Academy of Sciences.

[112]  G. Peters,et al.  Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor , 2010, The EMBO journal.

[113]  W. Bornmann,et al.  Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo: Therapeutic Implications , 2010, Molecular Cancer Therapeutics.

[114]  Min Jae Lee,et al.  Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14 , 2010, Nature.

[115]  Amith Panner,et al.  Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. , 2010, Cancer research.

[116]  Jimin Wang,et al.  Heterohexameric ring arrangement of the eukaryotic proteasomal ATPases: implications for proteasome structure and assembly. , 2010, Molecular cell.

[117]  Y. Surh,et al.  15-Deoxy-Δ12,14-prostaglandin J2 stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue , 2010, Oncogene.

[118]  R. Chen,et al.  The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling , 2010, Cell Research.

[119]  J. Rain,et al.  Synthesis and Biological Evaluation of 9‐Oxo‐9H‐indeno[1,2‐b]pyrazine‐2,3‐dicarbonitrile Analogues as Potential Inhibitors of Deubiquitinating Enzymes , 2010, ChemMedChem.

[120]  A. Gronenborn,et al.  Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1 , 2010, Proceedings of the National Academy of Sciences.

[121]  H. Clevers,et al.  Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl. , 2010, Molecular cell.

[122]  M. Pagano,et al.  The ubiquitin-specific protease USP47 is a novel β-TRCP interactor regulating cell survival , 2010, Oncogene.

[123]  J. Qin,et al.  USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalpha. , 2010, Cellular signalling.

[124]  S. Amslinger,et al.  The Tunable Functionality of α,β‐Unsaturated Carbonyl Compounds Enables Their Differential Application in Biological Systems , 2010, ChemMedChem.

[125]  F. Colland,et al.  Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase. , 2010, Experimental cell research.

[126]  J. Cheville,et al.  USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 , 2010, Cell.

[127]  M. Saville,et al.  Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy. , 2010, Seminars in cancer biology.

[128]  D. Lane,et al.  MdmX is a substrate for the deubiquitinating enzyme USP2a , 2010, Oncogene.

[129]  Michael J. Clague,et al.  Emerging roles of deubiquitinases in cancer‐associated pathways , 2010, IUBMB life.

[130]  F. Bazan,et al.  Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival , 2010, Nature.

[131]  K. Baek,et al.  The role of deubiquitinating enzymes in apoptosis , 2010, Cellular and Molecular Life Sciences.

[132]  A. Goldberg,et al.  Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. , 2009, Molecular cell.

[133]  H. Ichijo,et al.  Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death. , 2009, Molecular cell.

[134]  Y. Li,et al.  Regulation of Virus-triggered Signaling by OTUB1- and OTUB2-mediated Deubiquitination of TRAF3 and TRAF6* , 2009, The Journal of Biological Chemistry.

[135]  S. High,et al.  Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum , 2009, Journal of Cell Science.

[136]  W. Gu,et al.  Suppression of cancer cell growth by promoting cyclin D1 degradation. , 2009, Molecular cell.

[137]  M. Rapé,et al.  Building ubiquitin chains: E2 enzymes at work , 2009, Nature Reviews Molecular Cell Biology.

[138]  A. Jacobson,et al.  The Lysine 48 and Lysine 63 Ubiquitin Conjugates Are Processed Differently by the 26 S Proteasome* , 2009, The Journal of Biological Chemistry.

[139]  H. Tagawa,et al.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. , 2009, Blood.

[140]  D. Hammond,et al.  Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells , 2009, Current Biology.

[141]  L. Mei,et al.  The Proteasome-Associated Deubiquitinating Enzyme Usp14 Is Essential for the Maintenance of Synaptic Ubiquitin Levels and the Development of Neuromuscular Junctions , 2009, The Journal of Neuroscience.

[142]  Y. Rao,et al.  Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration , 2009, Proceedings of the National Academy of Sciences.

[143]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[144]  J. Rain,et al.  Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells , 2009, Molecular Cancer Therapeutics.

[145]  K. Lindsten,et al.  The ER‐resident ubiquitin‐specific protease 19 participates in the UPR and rescues ERAD substrates , 2009, EMBO reports.

[146]  D. Finley,et al.  Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.

[147]  Ying Zhang,et al.  DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors , 2009, Cell cycle.

[148]  Yigong Shi,et al.  Mechanism of substrate unfolding and translocation by the regulatory particle of the proteasome from Methanocaldococcus jannaschii. , 2009, Molecular cell.

[149]  W. Klapper,et al.  TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma , 2009, The Journal of experimental medicine.

[150]  A. Malovannaya,et al.  OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) α and Affects ERα Transcriptional Activity* , 2009, The Journal of Biological Chemistry.

[151]  J. F. Burrows,et al.  USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity* , 2009, Journal of Biological Chemistry.

[152]  John Rush,et al.  Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation , 2009, Cell.

[153]  E. Crivellato,et al.  The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis , 2009, Journal of Biological Chemistry.

[154]  S. Linder,et al.  Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin‐proteasome system , 2009, International journal of cancer.

[155]  R. Greenberg,et al.  The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks , 2009, Proceedings of the National Academy of Sciences.

[156]  D. Lane,et al.  Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53* , 2009, Journal of Biological Chemistry.

[157]  Yasushi Saeki,et al.  Lysine 63‐linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome , 2009, The EMBO journal.

[158]  Qiuyan Wang,et al.  ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells , 2009, Proceedings of the National Academy of Sciences.

[159]  Edward S. Miller,et al.  The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage , 2009, Cell.

[160]  V. Dixit,et al.  Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1 , 2009, Molecular and Cellular Biology.

[161]  Leonardo Morsut,et al.  FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination , 2009, Cell.

[162]  L. Pasqualucci,et al.  The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. , 2008, Blood.

[163]  K. Nakayama,et al.  USP19 Deubiquitinating Enzyme Supports Cell Proliferation by Stabilizing KPC1, a Ubiquitin Ligase for p27Kip1 , 2008, Molecular and Cellular Biology.

[164]  Tania A. Baker,et al.  Pore loops of the AAA+ ClpX machine grip substrates to drive translocation and unfolding , 2008, Nature Structural &Molecular Biology.

[165]  Jie Zhao,et al.  Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis , 2008, Journal of Molecular Medicine.

[166]  Erwin G. Van Meir,et al.  BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. , 2008, Cancer research.

[167]  Yong Yang,et al.  Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells. , 2008, Life sciences.

[168]  S. Chen,et al.  Endoplasmic reticulum stress contributes to the cell death induced by UCH-L1 inhibitor , 2008, Molecular and Cellular Biochemistry.

[169]  D. Sterner,et al.  Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities , 2008, Protein science : a publication of the Protein Society.

[170]  Ivan Dikic,et al.  Proteasome subunit Rpn13 is a novel ubiquitin receptor , 2008, Nature.

[171]  T. Iwakuma,et al.  The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. , 2008, Genes & development.

[172]  Yifan Cheng,et al.  Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. , 2008, Molecular cell.

[173]  Qiuyan Wang,et al.  Inhibition of p97-dependent Protein Degradation by Eeyarestatin I* , 2008, Journal of Biological Chemistry.

[174]  Mingyao Liu,et al.  Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. , 2008, Cancer research.

[175]  P. Evans,et al.  NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. , 2008, The Journal of biological chemistry.

[176]  H. Stunnenberg,et al.  A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. , 2008, Molecular cell.

[177]  Xiaohua Li,et al.  Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. , 2007, Molecular biology of the cell.

[178]  Hideki Ohdan,et al.  Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation. , 2008, Genes & development.

[179]  E. Pietras,et al.  A Deubiquitinase That Regulates Type I Interferon Production , 2007, Science.

[180]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[181]  Hengbin Wang,et al.  Regulation of cell cycle progression and gene expression by H2A deubiquitination , 2007, Nature.

[182]  Soyeon Park,et al.  Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. , 2007, Molecular cell.

[183]  Min Gyu Lee,et al.  p53 is regulated by the lysine demethylase LSD1 , 2007, Nature.

[184]  C. Dumontet,et al.  A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells , 2007, Oncogene.

[185]  G. Cuny,et al.  Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[186]  S. Elledge,et al.  The ubiquitin-specific protease USP28 is required for MYC stability , 2007, Nature Cell Biology.

[187]  Aedín C Culhane,et al.  RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites , 2007, Science.

[188]  S. Elledge,et al.  The tumor suppressor CYLD regulates entry into mitosis , 2007, Proceedings of the National Academy of Sciences.

[189]  F. Cañada,et al.  Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. , 2007, Biochemistry.

[190]  Viji M. Draviam,et al.  Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities , 2007, Nature.

[191]  Hengbin Wang,et al.  Role of H2A deubiquitination in cell cycle progression and Hox gene expression , 2007 .

[192]  M. Saville,et al.  The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2 , 2007, The EMBO journal.

[193]  G. Aldini,et al.  Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. , 2007, Biochemistry.

[194]  J. Morrow,et al.  Novel n-3 Fatty Acid Oxidation Products Activate Nrf2 by Destabilizing the Association between Keap1 and Cullin3* , 2007, Journal of Biological Chemistry.

[195]  J. E. V. van Leeuwen,et al.  UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-ubiquitination Promotes EGFR Degradation* , 2007, Journal of Biological Chemistry.

[196]  Kermit L. Carraway,et al.  Neuregulin-Induced ErbB3 Downregulation Is Mediated by a Protein Stability Cascade Involving the E3 Ubiquitin Ligase Nrdp1 , 2007, Molecular and Cellular Biology.

[197]  M. Miyazaki,et al.  Identification of methylation-silenced genes in colorectal cancer cell lines: Genomic screening using oligonucleotide arrays , 2007, Scandinavian journal of gastroenterology.

[198]  M. Rolfe,et al.  The JAMM motif of human deubiquitinase Poh1 is essential for cell viability , 2007, Molecular Cancer Therapeutics.

[199]  P. Tuchinda,et al.  Cytotoxic and anti-HIV-1 caged xanthones from the resin and fruits of Garcinia hanburyi. , 2006, Planta medica.

[200]  A. Goldberg,et al.  hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37 , 2006, The EMBO journal.

[201]  A. Heguy,et al.  Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human airway epithelium of cigarette smokers. , 2006, Cancer research.

[202]  G. Aldini,et al.  Lipoxidation‐Derived Reactive Carbonyl Species as Potential Drug Targets in Preventing Protein Carbonylation and Related Cellular Dysfunction , 2006, ChemMedChem.

[203]  S. Gygi,et al.  Deubiquitinating Enzyme Ubp6 Functions Noncatalytically to Delay Proteasomal Degradation , 2006, Cell.

[204]  Tohru Natsume,et al.  A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes , 2006, The EMBO journal.

[205]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[206]  C. Brancolini,et al.  Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. , 2006, Cancer research.

[207]  M. Washburn,et al.  Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1 , 2006, Nature Cell Biology.

[208]  T. Mak,et al.  A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response , 2006, Cell.

[209]  Zhiyou Wang,et al.  Prostaglandin J2 Alters Pro-survival and Pro-death Gene Expression Patterns and 26 S Proteasome Assembly in Human Neuroblastoma Cells* , 2006, Journal of Biological Chemistry.

[210]  R. Hartmann-Petersen,et al.  Adrm1, a putative cell adhesion regulating protein, is a novel proteasome-associated factor. , 2006, Journal of molecular biology.

[211]  K. Shuai,et al.  UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity , 2006, The EMBO journal.

[212]  G. Glinsky.  Genomic Models of Metastatic Cancer: Functional Analysis of Death-from-Cancer Signature Genes Reveals Aneuploid, Anoikis-Resistant, Metastasis-Enabling Phenotype with Altered Cell Cycle Control and Activated PcG Protein Chromatin Silencing Pathway , 2006, Cell cycle.

[213]  Ramin Massoumi,et al.  Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.

[214]  Xiaowei Chen,et al.  BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. , 2006, Cancer research.

[215]  I. Prior,et al.  The Ubiquitin Isopeptidase UBPY Regulates Endosomal Ubiquitin Dynamics and Is Essential for Receptor Down-regulation* , 2006, Journal of Biological Chemistry.

[216]  A. D’Andrea,et al.  Regulation of DNA repair by ubiquitylation , 2006, Nature Reviews Molecular Cell Biology.

[217]  S. Plassmann,et al.  An arginine/lysine‐rich motif is crucial for VCP/p97‐mediated modulation of ataxin‐3 fibrillogenesis , 2006, The EMBO journal.

[218]  Roberto Colombo,et al.  Protein carbonylation, cellular dysfunction, and disease progression , 2006, Journal of cellular and molecular medicine.

[219]  S. Gygi,et al.  Regulation of monoubiquitinated PCNA by DUB autocleavage , 2006, Nature Cell Biology.

[220]  B. Johansson,et al.  A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42 , 2006, Leukemia.

[221]  René Bernards,et al.  A Genomic and Functional Inventory of Deubiquitinating Enzymes , 2005, Cell.

[222]  Yigong Shi,et al.  Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14 , 2005, The EMBO journal.

[223]  B. Aggarwal,et al.  Curcumin: Getting Back to the Roots , 2005, Annals of the New York Academy of Sciences.

[224]  Ivan Dikic,et al.  Ubiquitylation and cell signaling , 2005, The EMBO journal.

[225]  K. Uchida,et al.  Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. , 2005, Biochemistry.

[226]  P. Kloetzel,et al.  The Zinc Finger of the CSN-Associated Deubiquitinating Enzyme USP15 Is Essential to Rescue the E3 Ligase Rbx1 , 2005, Current Biology.

[227]  T. Golub,et al.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.

[228]  A. Holmgren,et al.  Thioredoxin Reductase Is Irreversibly Modified by Curcumin , 2005, Journal of Biological Chemistry.

[229]  M. Sporn,et al.  Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action. , 2005, Bioorganic & medicinal chemistry letters.

[230]  N. Kamiya,et al.  α,β-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor γ* , 2005, Journal of Biological Chemistry.

[231]  E. Messing,et al.  VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α , 2005, EMBO reports.

[232]  T. Toda,et al.  CSN facilitates Cullin–RING ubiquitin ligase function by counteracting autocatalytic adapter instability , 2005, Nature Cell Biology.

[233]  Barrington G. Burnett,et al.  The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[234]  René Bernards,et al.  The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. , 2005, Molecular cell.

[235]  J. Castro,et al.  Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[236]  N. Kamiya,et al.  Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. , 2005, The Journal of biological chemistry.

[237]  C. Pickart,et al.  Ubiquitin: structures, functions, mechanisms. , 2004, Biochimica et biophysica acta.

[238]  Q. You,et al.  Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. , 2004, Biological & pharmaceutical bulletin.

[239]  S. Aaronson,et al.  BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage , 2004, Molecular and Cellular Biology.

[240]  Xiuli Wu,et al.  Stabilization of the E3 Ubiquitin Ligase Nrdp1 by the Deubiquitinating Enzyme USP8 , 2004, Molecular and Cellular Biology.

[241]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[242]  M. Figueiredo-Pereira,et al.  Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. , 2004, Biochemical and biophysical research communications.

[243]  D. Finley,et al.  Rad23 and Rpn10 Serve as Alternative Ubiquitin Receptors for the Proteasome* , 2004, Journal of Biological Chemistry.

[244]  Motomi Osato.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia , 2004, Oncogene.

[245]  C. Ireland,et al.  Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. , 2004, Journal of medicinal chemistry.

[246]  R. Hartmann-Petersen,et al.  Integral UBL domain proteins: a family of proteasome interacting proteins. , 2004, Seminars in cell & developmental biology.

[247]  Carlo Rago,et al.  Tumour suppression: Disruption of HAUSP gene stabilizes p53 , 2004, Nature.

[248]  H. Ploegh,et al.  Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin. , 2004, Molecular biology of the cell.

[249]  Muyang Li,et al.  A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.

[250]  J. Fletcher,et al.  USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst , 2004, Cancer Research.

[251]  M. Loda,et al.  The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. , 2004, Cancer cell.

[252]  Erich A Nigg,et al.  Aurora kinases link chromosome segregation and cell division to cancer susceptibility. , 2004, Current opinion in genetics & development.

[253]  M. Glickman,et al.  Complementary Roles for Rpn11 and Ubp6 in Deubiquitination and Proteolysis by the Proteasome* , 2004, Journal of Biological Chemistry.

[254]  S. Kasibhatla,et al.  Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. , 2004, Bioorganic & medicinal chemistry.

[255]  D. Rees,et al.  JAMM: A Metalloprotease-Like Zinc Site in the Proteasome and Signalosome , 2003, PLoS biology.

[256]  K. Uchida,et al.  Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. , 2004, Chemical research in toxicology.

[257]  W. Dalton,et al.  The proteasome. , 2004, Seminars in oncology.

[258]  A. Goldberg,et al.  Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.

[259]  R. Shiekhattar,et al.  Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. , 2003, Molecular cell.

[260]  E. J. V. van Zoelen,et al.  Ligand-induced Lysosomal Epidermal Growth Factor Receptor (EGFR) Degradation Is Preceded by Proteasome-dependent EGFR De-ubiquitination* , 2003, Journal of Biological Chemistry.

[261]  A. Rao.  Faculty Opinions recommendation of CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. , 2003 .

[262]  R. Perez-soler,et al.  Reactive Oxygen Species Generation and Mitochondrial Dysfunction in the Apoptotic Response to Bortezomib, a Novel Proteasome Inhibitor, in Human H460 Non-small Cell Lung Cancer Cells* , 2003, Journal of Biological Chemistry.

[263]  Peter T Lansbury,et al.  Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. , 2003, Chemistry & biology.

[264]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[265]  P. Masson,et al.  Use of RNA Interference and Complementation To Study the Function of the Drosophila and Human 26S Proteasome Subunit S13 , 2003, Molecular and Cellular Biology.

[266]  J. Harney,et al.  Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. , 2003, The Journal of clinical investigation.

[267]  H. Masutani,et al.  Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins* , 2003, Journal of Biological Chemistry.

[268]  T. Blundell,et al.  A Novel Type of Deubiquitinating Enzyme* , 2003, Journal of Biological Chemistry.

[269]  H. Stein,et al.  Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation , 2003, The Journal of pathology.

[270]  K. Hofmann,et al.  When ubiquitin meets ubiquitin receptors: a signalling connection , 2003, Nature Reviews Molecular Cell Biology.

[271]  C. Semple,et al.  The comparative proteomics of ubiquitination in mouse. , 2003, Genome research.

[272]  Pier Paolo Di Fiore,et al.  Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation , 2003, Nature Cell Biology.

[273]  M. Balakirev,et al.  Otubains: a new family of cysteine proteases in the ubiquitin pathway , 2003, EMBO reports.

[274]  P. Cassidy,et al.  Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase* , 2003, The Journal of Biological Chemistry.

[275]  Thomas Lengauer,et al.  Structural modeling of ataxin‐3 reveals distant homology to adaptins , 2002, Proteins.

[276]  C. Fletcher,et al.  Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease , 2002, Nature Genetics.

[277]  A. Goldberg,et al.  Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[278]  H. Ploegh,et al.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.

[279]  T. Yao,et al.  A cryptic protease couples deubiquitination and degradation by the proteasome , 2002, Nature.

[280]  M. Glickman,et al.  MPN+, a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function , 2002, BMC Biochemistry.

[281]  Vahan B. Indjeian,et al.  CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. , 2002, Developmental cell.

[282]  Wan-Wan Lin,et al.  Proteasome inhibitors stimulate activator protein‐1 pathway via reactive oxygen species production , 2002, FEBS letters.

[283]  L. Aravind,et al.  Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26S Proteasome , 2002, Science.

[284]  K. Zerres,et al.  Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. , 2002, The Journal of investigative dermatology.

[285]  F. Fitzpatrick,et al.  Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. , 2002, Molecular pharmacology.

[286]  Sharon L R Kardia,et al.  Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[287]  Sridhar Ramaswamy,et al.  Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability , 2002, Cell.

[288]  T. Mizushima,et al.  The structure of the mammalian 20S proteasome at 2.75 A resolution. , 2002, Structure.

[289]  J. Qin,et al.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.

[290]  Dong-er Zhang,et al.  UBP43 (USP18) Specifically Removes ISG15 from Conjugated Proteins* , 2002, The Journal of Biological Chemistry.

[291]  K. Carraway,et al.  An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[292]  E. Messing,et al.  Ubiquitination of a Novel Deubiquitinating Enzyme Requires Direct Binding to von Hippel-Lindau Tumor Suppressor Protein* , 2002, The Journal of Biological Chemistry.

[293]  R. Weinberg,et al.  hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.

[294]  H. Ploegh,et al.  A novel active site‐directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14 , 2001, The EMBO journal.

[295]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[296]  F. Fitzpatrick,et al.  Cyclopentenone Prostaglandins of the J Series Inhibit the Ubiquitin Isopeptidase Activity of the Proteasome Pathway* , 2001, The Journal of Biological Chemistry.

[297]  V. Noskov,et al.  Discovery of a novel, paternally expressed ubiquitin-specific processing protease gene through comparative analysis of an imprinted region of mouse chromosome 7 and human chromosome 19q13.4. , 2000, Genome research.

[298]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[299]  H. Yang,et al.  Identification of a 26S proteasome-associated UCH in fission yeast. , 2000, Biochemical and biophysical research communications.

[300]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[301]  A. Ciechanover,et al.  The ubiquitin‐mediated proteolytic pathway: Mode of action and clinical implications , 2000, Journal of cellular biochemistry. Supplement.

[302]  D. Jensen,et al.  Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1. , 1999, Cancer letters.

[303]  V. Marchesi,et al.  A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[304]  W. Baumeister,et al.  The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.

[305]  M. Peter,et al.  Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid* , 1998, The Journal of Biological Chemistry.

[306]  M. Bolotin-Fukuhara,et al.  A mutation in a novel yeast proteasomal gene, RPN11/MPR1, produces a cell cycle arrest, overreplication of nuclear and mitochondrial DNA, and an altered mitochondrial morphology. , 1998, Molecular biology of the cell.

[307]  W. Baumeister,et al.  A Subcomplex of the Proteasome Regulatory Particle Required for Ubiquitin-Conjugate Degradation and Related to the COP9-Signalosome and eIF3 , 1998, Cell.

[308]  N. Nomura,et al.  UBPY: a growth‐regulated human ubiquitin isopeptidase , 1998, The EMBO journal.

[309]  M. Majeed,et al.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.

[310]  Keith D Wilkinson,et al.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression , 1998, Oncogene.

[311]  A. Amerik,et al.  In vivo disassembly of free polyubiquitin chains by yeast Ubp14 modulates rates of protein degradation by the proteasome , 1997, The EMBO journal.

[312]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[313]  R. Everett,et al.  A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.

[314]  T. Ishikawa,et al.  Chemical Implications for Antitumor and Antiviral Prostaglandins: Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols , 1997 .

[315]  Wei Xu,et al.  Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome , 1997, Nature.

[316]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.

[317]  Q. Deveraux,et al.  Molecular Cloning and Expression of a 26 S Protease Subunit Enriched in Dileucine Repeats (*) , 1995, The Journal of Biological Chemistry.

[318]  Geoffrey A. Cordell,et al.  Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis , 1995, Nature Medicine.

[319]  S. Jentsch,et al.  Selective protein degradation: A journey's end within the proteasome , 1995, Cell.

[320]  R. Huber,et al.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.

[321]  Genes, chromosomes & cancer , 1995 .

[322]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[323]  D. Buchhagen,et al.  Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3‐3p21.3 in sporadic breast‐cancer development , 1994, International journal of cancer.

[324]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[325]  G. Rubin,et al.  The fat facets gene is required for Drosophila eye and embryo development. , 1992, Development.

[326]  K. Loeb,et al.  The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. , 1992, The Journal of biological chemistry.

[327]  R Hegerl,et al.  Subunit stoichiometry and three‐dimensional arrangement in proteasomes from Thermoplasma acidophilum. , 1992, The EMBO journal.

[328]  W Baumeister,et al.  Primary structure of the Thermoplasma proteasome and its implications for the structure, function, and evolution of the multicatalytic proteinase. , 1992, Biochemistry.

[329]  A. Hershko,et al.  A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. , 1992, The Journal of biological chemistry.

[330]  D. Ecker,et al.  A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. , 1989, Science.

[331]  A. Haas,et al.  Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. , 1987, The Journal of biological chemistry.

[332]  S. Narumiya,et al.  Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. , 1986, The Journal of pharmacology and experimental therapeutics.

[333]  F. Fitzpatrick,et al.  Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. , 1983, The Journal of biological chemistry.

[334]  A. Ciechanover,et al.  Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. , 1983, The Journal of biological chemistry.

[335]  A. Goldberg,et al.  ATP serves two distinct roles in protein degradation in reticulocytes, one requiring and one independent of ubiquitin , 1983, The Journal of cell biology.

[336]  H. K. Koticha.  ANEURYSMAL BONE CYST. , 1965, Indian journal of medical sciences.